| Trial ID: | L0828 |
| Source ID: | IRCT201612077732N2
|
| Associated Drug: |
Vitamin D
|
| Title: |
Vitamin D supplementation for the treatment of non alcoholic fatty liver disease: a randomized double blind placebo controlled trial
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NON ALCOHOLIC FATTY LIVER DISEASE.
|
| Interventions: |
Intervention 1: Intervention group 1:50000 U vitamin D3 (cholecalciferol) pearl (Zahravi Pharmacutical Co) per week for 3 months. Intervention 2: Intervention group 2 : Intervention group 2: 0.25 mg calcitriol (1,25 dihydroxycholecalciferol) pearl (Zahra
|
| Outcome Measures: |
Liver enzymes. Timepoint: begining of the study-3 months after. Method of measurement: biochemicl kit.Lipid profile and plasma glucose. Timepoint: begining of the study- 3 months later. Method of measurement: Biochemical kit.
|
| Sponsor/Collaborators: |
Vice Chancellor for Research, Shiraz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years75 years
|
| Phases: |
Phase 1
|
| Enrollment: |
106
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
26/02/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/8180
|
